Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.7 |
mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |